{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "129",
          "submission_status": "AP",
          "submission_status_date": "20191217",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "61329",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125117s129lbl.pdf",
              "date": "20191218",
              "type": "Label"
            },
            {
              "id": "61363",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/125117Orig1s129ltr.pdf",
              "date": "20191220",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "131",
          "submission_status": "AP",
          "submission_status_date": "20240710",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "79043",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/125117Orig1s131ltr.pdf",
              "date": "20240711",
              "type": "Letter"
            },
            {
              "id": "79078",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125117s131lbl.pdf",
              "date": "20240715",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "111",
          "submission_status": "AP",
          "submission_status_date": "20130326",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "39848",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125117s111lbl.pdf",
              "date": "20130401",
              "type": "Label"
            },
            {
              "id": "31836",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/125117Orig1s111ltr.pdf",
              "date": "20130329",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "132",
          "submission_status": "AP",
          "submission_status_date": "20240912",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "79586",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125117s132lbl.pdf",
              "date": "20240916",
              "type": "Label"
            },
            {
              "id": "79614",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/125117Orig1s132ltr.pdf",
              "date": "20240916",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "88",
          "submission_status": "AP",
          "submission_status_date": "20110428",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "39846",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/125117s0086s0088s0090lbl.pdf",
              "date": "20110429",
              "type": "Label"
            },
            {
              "id": "31835",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/125117s086s088s090ltr.pdf",
              "date": "20110505",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "86",
          "submission_status": "AP",
          "submission_status_date": "20110428",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "18794",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/125117s0086s0088s0090lbl.pdf",
              "date": "20110429",
              "type": "Label"
            },
            {
              "id": "31834",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/125117s086s088s090ltr.pdf",
              "date": "20110505",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "90",
          "submission_status": "AP",
          "submission_status_date": "20110428",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "39847",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/125117s0086s0088s0090lbl.pdf",
              "date": "20110429",
              "type": "Label"
            },
            {
              "id": "9613",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/125117s086s088s090ltr.pdf",
              "date": "20110505",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20050531",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "9612",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/125117_0000_ltr.pdf",
              "date": "20050607",
              "type": "Letter"
            },
            {
              "id": "18793",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/125117_0000_lbl.pdf",
              "date": "20050607",
              "type": "Label"
            },
            {
              "id": "22785",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2005/125117s000_NaglazyneTOC.html",
              "date": "20050913",
              "type": "Review"
            }
          ]
        }
      ],
      "application_number": "BLA125117",
      "sponsor_name": "BIOMARIN",
      "openfda": {
        "application_number": [
          "BLA125117"
        ],
        "brand_name": [
          "NAGLAZYME"
        ],
        "generic_name": [
          "GALSULFASE"
        ],
        "manufacturer_name": [
          "BioMarin Pharmaceutical Inc."
        ],
        "product_ndc": [
          "68135-020"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "GALSULFASE"
        ],
        "rxcui": [
          "578037",
          "584222"
        ],
        "spl_id": [
          "02482a8a-8333-4e9c-a9dc-ff7780f40363"
        ],
        "spl_set_id": [
          "59341250-deac-ed71-3823-a4f5d64dbd77"
        ],
        "package_ndc": [
          "68135-020-01"
        ],
        "nui": [
          "M0000794",
          "N0000175823"
        ],
        "pharm_class_cs": [
          "alpha-Glucosidases [CS]"
        ],
        "pharm_class_epc": [
          "Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]"
        ],
        "unii": [
          "59UA429E5G"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "NAGLAZYME",
          "active_ingredients": [
            {
              "name": "GALSULFASE",
              "strength": "5MG/5ML"
            }
          ],
          "dosage_form": "INJECTABLE",
          "route": "INJECTION",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}